Cart
sales@molnova.com
Momordicoside A
CAS No. 75801-95-5
Momordicoside A( ——— )
Catalog No. M38806 CAS No. 75801-95-5
Momordicoside A is isolated from Momordica charantia L. Momordicoside A has the inhibitory effect on protein tyrosine phosphatase (PTP1B).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 275 | In Stock |
|
| 10MG | 407 | In Stock |
|
| 25MG | 663 | In Stock |
|
| 50MG | 910 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMomordicoside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionMomordicoside A is isolated from Momordica charantia L. Momordicoside A has the inhibitory effect on protein tyrosine phosphatase (PTP1B).
-
DescriptionMomordicoside A has the inhibition effect on PIP1B.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number75801-95-5
-
Formula Weight817.023
-
Molecular FormulaC42H72O15
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (122.40 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. SHI Xue-ping, et al. Isolation of the saponins from Momordica charantia and their PTP1B inhibition activity. Journal of Shaanxi Normal University,2008 ,36 (4) :63-67.
molnova catalog
related products
-
L-m-Tyrosine
L-(-)-m-Tyrosine is a non-natural amino acid. L-(-)-m-Tyrosine displays the potential in treating Parkinson's disease, arthritis, and Alzheimer's disease.
-
Propiverine hydrochl...
Propiverine is a widely used antimuscarinic drug with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB).
-
TRAP-7;Thrombin Rece...
TRAP-7 is a thrombin receptor (PAR) activating peptide. TRAP-7 stimulates total inositol phosphate (IP) accumulation and phosphorylation of a specific endogenous substrate for activated PKC. TRAP-7 can be used in cardiovascular disease research.
